Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 1
2000 2
2005 1
2006 1
2012 4
2013 1
2014 2
2015 3
2016 2
2017 8
2018 5
2019 5
2020 4
2021 4
2022 8
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Metastatic Non-Functioning Neuroendocrine Tumor"
Page 1
Sporadic pancreatic neuroendocrine tumor: Surgery of the primary tumor.
Deguelte S, de Mestier L, Hentic O, Cros J, Lebtahi R, Hammel P, Kianmanesh R. Deguelte S, et al. J Visc Surg. 2018 Dec;155(6):483-492. doi: 10.1016/j.jviscsurg.2018.08.010. Epub 2018 Nov 15. J Visc Surg. 2018. PMID: 30448206 Free article. Review.
The management of patients with sporadic pancreatic neuroendocrine tumors (PNET) is multi-disciplinary and often, multimodal. ...The update reviews the operative indications and the different surgical techniques available (including parenchymal-sparing surgery) to t …
The management of patients with sporadic pancreatic neuroendocrine tumors (PNET) is multi-disciplinary and often, multimodal. …
Clinical implications of cell-of-origin epigenetic characteristics in non-functional pancreatic neuroendocrine tumors.
Dreijerink KM, Hackeng WM, Singhi AD, Heaphy CM, Brosens LA. Dreijerink KM, et al. J Pathol. 2022 Feb;256(2):143-148. doi: 10.1002/path.5834. Epub 2021 Dec 18. J Pathol. 2022. PMID: 34750813 Review.
Primary non-functional pancreatic neuroendocrine tumors (NF-PanNETs) are a heterogeneous group of neuroendocrine neoplasms that display highly variable clinical behavior. Therefore, NF-PanNETs often present clinical teams with a dilemma: the uncertain meta …
Primary non-functional pancreatic neuroendocrine tumors (NF-PanNETs) are a heterogeneous group of neuroendocrine neopla …
Management of small, asymptomatic, non-functioning pancreatic neuroendocrine tumours: follow-up, ablation, or surgery?
Dąbkowski K, Starzyńska T. Dąbkowski K, et al. Endokrynol Pol. 2023;74(1):25-30. doi: 10.5603/EP.a2022.0080. Epub 2022 Dec 15. Endokrynol Pol. 2023. PMID: 36519652 Free article. Review.
Non-functioning pancreatic neuroendocrine tumours (NF-pNETs) are potentially malignant neoplasms that are detected with increasing frequency. ...However, some studies show metastatic potential of these tumours, fuelling an ongoing debate in the literat …
Non-functioning pancreatic neuroendocrine tumours (NF-pNETs) are potentially malignant neoplasms that are detected with …
Recent Updates in the Management of Advanced Pancreatic Neuroendocrine Tumors.
Cho CM. Cho CM. Korean J Gastroenterol. 2019 Mar 25;73(3):124-131. doi: 10.4166/kjg.2019.73.3.124. Korean J Gastroenterol. 2019. PMID: 31013555 Free article. Review.
Pancreatic neuroendocrine tumors (pNETs) are rare neoplasms arising from the pancreatic islet of Langerhans and can be functioning or non-functioning based on the clinical symptoms caused by hormonal secretions. PNETs are the second most common tumo …
Pancreatic neuroendocrine tumors (pNETs) are rare neoplasms arising from the pancreatic islet of Langerhans and can be functio …
Life expectancy in pancreatic neuroendocrine cancer.
Brooks JC, Shavelle RM, Vavra-Musser KN. Brooks JC, et al. Clin Res Hepatol Gastroenterol. 2019 Feb;43(1):88-97. doi: 10.1016/j.clinre.2018.08.005. Epub 2018 Sep 13. Clin Res Hepatol Gastroenterol. 2019. PMID: 30220478
We calculated life expectancies for patients with less common pancreatic neuroendocrine tumors (PNETs), and also for the subsets of these patients who survive 1 and 5 years post-diagnosis, all of which carry a significantly better prognosis. ...Functioning PNETs wer …
We calculated life expectancies for patients with less common pancreatic neuroendocrine tumors (PNETs), and also for the subse …
Solid non-functioning endocrine tumors of the pancreas: correlating computed tomography and pathology.
Zamboni GA, Ambrosetti MC, Zivelonghi C, Lombardo F, Butturini G, Cingarlini S, Capelli P, Pozzi Mucelli R. Zamboni GA, et al. HPB (Oxford). 2017 Nov;19(11):986-991. doi: 10.1016/j.hpb.2017.06.013. Epub 2017 Aug 4. HPB (Oxford). 2017. PMID: 28784262 Free article.
BACKGROUND: Since prognosis and treatment of pancreatic endocrine tumors (pNET) are based on tumor grade, contrast-enhanced multidetector computed tomography (MDCT) features of solid non-functioning pNETs were studied and correlated with pathology t …
BACKGROUND: Since prognosis and treatment of pancreatic endocrine tumors (pNET) are based on tumor grade, contrast-enhanced mu …
Update on Current Evidence for the Diagnosis and Management of Nonfunctioning Pituitary Neuroendocrine Tumors.
Whyte E, Nezu M, Chik C, Tateno T. Whyte E, et al. Endocrinol Metab (Seoul). 2023 Dec;38(6):631-654. doi: 10.3803/EnM.2023.1838. Epub 2023 Nov 15. Endocrinol Metab (Seoul). 2023. PMID: 37964483 Free PMC article. Review.
Pituitary neuroendocrine tumors (PitNETs) are the third most frequently diagnosed intracranial tumors, with nonfunctioning PitNETs (nfPitNETs) accounting for 30% of all pituitary tumors and representing the most common type of macroPitNETs. NfPitNETs a …
Pituitary neuroendocrine tumors (PitNETs) are the third most frequently diagnosed intracranial tumors, with nonfunction …
Sporadic, non-functional, gastrin-producing duodenal neuroendocrine tumors: A retrospective study of an infrequent disease.
de Jorge Huerta L, Solares Fernández I, Sánchez-Moreno B, Males Maldonado D, de Ibarrola Andrés C, Díaz-Simón R. de Jorge Huerta L, et al. J Dig Dis. 2022 Aug;23(8-9):455-461. doi: 10.1111/1751-2980.13129. Epub 2022 Nov 10. J Dig Dis. 2022. PMID: 36168962 Free PMC article.
OBJECTIVES: Non-functioning gastrin-producing neuroendocrine neoplasms (NEN) of the duodenum are rare gastrointestinal tumors without a clinical syndrome due to gastrin production. ...Local resection was applied in most cases as curative treatment. The …
OBJECTIVES: Non-functioning gastrin-producing neuroendocrine neoplasms (NEN) of the duodenum are rare gastrointestinal …
Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trial.
Corti F, Brizzi MP, Amoroso V, Giuffrida D, Panzuto F, Campana D, Prinzi N, Milione M, Cascella T, Spreafico C, Randon G, Oldani S, Leporati R, Scotto G, Pulice I, Stocchetti BL, Porcu L, Coppa J, Di Bartolomeo M, de Braud F, Pusceddu S. Corti F, et al. BMC Cancer. 2023 Sep 26;23(1):908. doi: 10.1186/s12885-023-11287-2. BMC Cancer. 2023. PMID: 37752423 Free PMC article.
BACKGROUND: Well-differentiated (WD) neuroendocrine tumors (NETs) are a group of rare neoplasms with limited therapeutic options. ...Eligible patients have to meet the following inclusion criteria: diagnosis of advanced or metastatic, progressive, non- …
BACKGROUND: Well-differentiated (WD) neuroendocrine tumors (NETs) are a group of rare neoplasms with limited therapeutic optio …
Alternative Lengthening of Telomeres and Differential Expression of Endocrine Transcription Factors Distinguish Metastatic and Non-metastatic Insulinomas.
Hackeng WM, Schelhaas W, Morsink FHM, Heidsma CM, van Eeden S, Valk GD, Vriens MR, Heaphy CM, Nieveen van Dijkum EJM, Offerhaus GJA, Dreijerink KMA, Brosens LAA. Hackeng WM, et al. Endocr Pathol. 2020 Jun;31(2):108-118. doi: 10.1007/s12022-020-09611-8. Endocr Pathol. 2020. PMID: 32103422 Free PMC article.
Insulin-producing pancreatic neuroendocrine tumors (PanNETs)/insulinomas are generally considered to be indolent tumors with an excellent prognosis after complete resection. ...In addition, WHO grade and loss of ATRX or DAXX were determined by immunohistochem …
Insulin-producing pancreatic neuroendocrine tumors (PanNETs)/insulinomas are generally considered to be indolent tumors …
48 results